Alessandro CFA - Vinci Partners CEO Director
| VINP Stock | USD 10.78 0.24 2.28% |
Insider
Alessandro CFA is CEO Director of Vinci Partners Investments
| Age | 54 |
| Address | Av. Bartolomeu Mitre, 336, Rio De Janeiro, RJ, Brazil, 22431-002 |
| Phone | 55 21 2159 6240 |
| Web | https://www.vincipartners.com |
Vinci Partners Management Efficiency
The company has return on total asset (ROA) of 0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1727 %, meaning that it created $0.1727 on every $100 dollars invested by stockholders. Vinci Partners' management efficiency ratios could be used to measure how well Vinci Partners manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/04/2024, Return On Tangible Assets is likely to drop to 0.10. In addition to that, Return On Capital Employed is likely to drop to 0.09. At this time, Vinci Partners' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 06/04/2024, Non Current Liabilities Total is likely to grow to about 717.8 M, while Total Current Liabilities is likely to drop slightly above 151.1 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carl DeLuca | LiCycle Holdings Corp | 55 | |
| Deborah Simpson | LiCycle Holdings Corp | 57 | |
| Lauren Choate | LiCycle Holdings Corp | 66 | |
| Dawei Li | LiCycle Holdings Corp | 41 | |
| Xudong Feng | Koppers Holdings | 62 | |
| Ann Challis | Goosehead Insurance | N/A | |
| Scott Prochazka | LiCycle Holdings Corp | 55 | |
| Jared Sinclair | Goosehead Insurance | N/A | |
| Stephanie Apostolou | Koppers Holdings | 43 | |
| Mark Wellings | LiCycle Holdings Corp | 57 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Tracie McCormick | Koppers Holdings | N/A | |
| Anthony Tse | LiCycle Holdings Corp | 50 | |
| Rick Findlay | LiCycle Holdings Corp | 63 | |
| Tim Johnston | LiCycle Holdings Corp | 35 | |
| RPh Pharm | Collegium Pharmaceutical | 60 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Kunal Phalpher | LiCycle Holdings Corp | 37 | |
| Bradley Pearce | Koppers Holdings | 57 | |
| Jessica Franklin | Koppers Holdings | N/A | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0639 |
Vinci Partners Inves Leadership Team
Elected by the shareholders, the Vinci Partners' board of directors comprises two types of representatives: Vinci Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vinci. The board's role is to monitor Vinci Partners' management team and ensure that shareholders' interests are well served. Vinci Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vinci Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alessandro CFA, CEO Director | ||
| Sergio Ribeiro, COO CFO | ||
| Anna Santos, Investor Manager | ||
| Bruno Zaremba, Chairman Relations |
Vinci Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vinci Partners a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0639 | ||||
| Profit Margin | 0.51 % | ||||
| Operating Margin | 0.43 % | ||||
| Current Valuation | (490.13 M) | ||||
| Shares Outstanding | 38.78 M | ||||
| Shares Owned By Insiders | 32.80 % | ||||
| Shares Owned By Institutions | 22.81 % | ||||
| Number Of Shares Shorted | 25.44 K | ||||
| Price To Earning | 14.99 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Vinci Stock Analysis
When running Vinci Partners' price analysis, check to measure Vinci Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vinci Partners is operating at the current time. Most of Vinci Partners' value examination focuses on studying past and present price action to predict the probability of Vinci Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vinci Partners' price. Additionally, you may evaluate how the addition of Vinci Partners to your portfolios can decrease your overall portfolio volatility.